AlzChem Group AG (FRA:ACT)

Market Cap	791.76M
Revenue (ttm)	571.53M
Net Income (ttm)	54.08M
Shares Out	n/a
EPS (ttm)	5.31
PE Ratio	14.64
Forward PE	n/a
Dividend	1.80 (2.31%)
Ex-Dividend Date	May 9, 2025

Volume	38,072
Average Volume	16,973
Open	73.80
Previous Close	73.60
Day's Range	73.80 - 78.60
52-Week Range	25.80 - 78.60
Beta	n/a
RSI	77.82
Earnings Date	Feb 28, 2025

About AlzChem Group AG

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the...

• Industry: Chemicals and Allied Products
• Founded: 1908
• Employees: 1,708
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ACT

Financial Performance

In 2024, AlzChem Group AG's revenue was 571.53 million, an increase of 4.72% compared to the previous year's 545.79 million. Earnings were 54.08 million, an increase of 56.19%.